Moonlight human ribosomal protein L13a downregulation is associated with p53 and HER2/neu expression in breast cancer.

Molavi, Ghader; Samadi, Nasser; Hashemzadeh, Shahriar; Halimi, Monireh; Hosseingholi, Elaheh Zadeh

Molavi, Ghader; Samadi, Nasser; Hashemzadeh, Shahriar; Halimi, Monireh; Hosseingholi, Elaheh Zadeh.

Afiliación

Molavi G; Tabriz University of Medical Sciences, Drug Applied Research Center, Tabriz, Iran.
Samadi N; Tabriz University of Medical Sciences, Faculty of Advanced Medical Sciences, Department of Molecular Medicine, Tabriz, Iran.
Hashemzadeh S; Tabriz University of Medical Sciences, Drug Applied Research Center, Tabriz, Iran.
Halimi M; Tabriz University of Medical Sciences, Faculty of Advanced Medical Sciences, Department of Molecular Medicine, Tabriz, Iran.
Hosseingholi EZ; Tabriz University of Medical Sciences, Faculty of Medicine, Department of Biochemistry, Tabriz, Iran.

J Appl Biomed ; 18(2-3): 46-53, 2020 08.

Article en En | MEDLINE | ID: mdl-34907725

Asunto(s)

Neoplasias de la Mama; Receptor ErbB-2; Proteínas Ribosómicas; Neoplasias de la Mama/genética; Regulación hacia Abajo; Femenino; Humanos; ARN Mensajero/genética; Proteínas de Unión al ARN/genética; Receptor ErbB-2/genética; Receptor ErbB-2/metabolismo; Proteínas Ribosómicas/genética; Proteínas Ribosómicas/metabolismo; Proteína p53 Supresora de Tumor/genética; Proteína p53 Supresora de Tumor/metabolismo

Palabras clave

Breast neoplasms; ErbB receptors; Ribosomal proteins; Tumor suppressor protein p53

Texto completo

Imprimir

XML

PubMed Links

Buscar en Google

Texto completo: 1 Bases de datos: MEDLINE Asunto principal: Proteínas Ribosómicas / Neoplasias de la Mama / Receptor ErbB-2 Tipo de estudio: Risk_factors_studies Límite: Female / Humans Idioma: En Revista: J Appl Biomed Año: 2020 Tipo del documento: Article País de afiliación: Irán

Texto completo

Imprimir

XML

PubMed Links

Buscar en Google